Fast Market Research

Global Female Contraceptive Market 2016-2020 - New Market Research Report

Fast Market Research announces the availability of the new TechNavio report, "Global Female Contraceptive Market 2016-2020", on their comprehensive research portal


Boston, MA -- (SBWIRE) -- 11/30/2016 -- Adolescent fertility regulation and pregnancy prevention are important healthcare issues today. Although it is difficult to gauge the full extent of the unmet need for contraception, there is a great need for reproductive and sexual health education owing to the rise in STDs. Research suggests that behavior in adolescence results in a pattern for the rest of an individual's life. The absence of sexual and reproductive healthcare programs for adolescents can result in unwanted pregnancies and unsafe abortions.

Technavio's analysts forecast the global female contraceptive market to grow at a CAGR of 3.48% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global female contraceptives market for 2016-2020. To calculate the market size, the report considers the revenue generated from the overall retail sales of female contraceptive products globally.

Get More Details on this Report and a Full Table of Contents at Global Female Contraceptive Market 2016-2020

The market is divided into the following segments based on geography:


Technavio's report, Global Female Contraceptives 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-Merck Millipore
-Teva Pharmaceuticals

Other prominent vendors

-Agile Therapeutics
-Bayer Pharma
-Ferring Pharmaceuticals
-Female Health
-Fuji Latex
-HLL Lifecare
-Janssen Pharmaceuticals
-Lupin Pharmaceuticals
-Mayer Laboratories
-Okamoto Industries
-Reckitt Benckiser
-Syzygy Healthcare
-V-Care Pharma

Market driver

-Growing importance of family planning
-For a full, detailed list, view our report

Market challenge

-High cost and inaccessibility of health services
-For a full, detailed list, view our report

Market trend

-Growing cases of sexually transmitted diseases (STDs)
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Allergan, Merck Millipore, Pfizer, Teva, Afaxys, Agile Therapeutics, Ansell, Bayer Pharma, Caya, Ferring Pharmaceuticals, Female Health, Fuji Latex, HLL Lifecare, Janssen Pharmaceuticals, Lipocine, Lupin Pharmaceuticals, Mayer Laboratories, Okamoto Industries, Reckitt Benckiser, Syzygy Healthcare, V-Care Pharma

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:
-Global Sexual Wellness Market 2016-2020
-Global Fertilty Services Market 2016-2020
-Female Sexual Dysfunction Global Clinical Trials Review, H2, 2015
-Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2015
-Female Contraception - Pipeline Review, H1 2016